Berger Financial Group, Inc
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 1826136
Plymouth, MN
Position in LXRX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$24,000
+$8,400 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#117
of 148 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Berger Financial Group, Inc holds $1,156,180 across 3 Biotechnology names. LXRX ranks #3 (2.1% of the industry book) .
All Filings in LXRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,000 | 10,000 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $15,600 | 10,000 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $11,500 | 10,000 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $14,754 | 10,929 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $10,382 | 10,929 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $5,027 | 10,929 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,087 | 10,929 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,158 | 10,929 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18,360 | 10,929 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $26,229 | 10,929 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $16,721 | 10,929 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $11,912 | 10,929 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $25,027 | 10,929 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $26,557 | 10,929 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $20,874 | 10,929 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $26,229 | 10,929 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $20,327 | 10,929 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $22,841 | 10,929 | Shares | Sole | 2022-05-10 | |
| No filing history on record for this holder in this stock. | ||||||